Keywords: oscient, 1st-qtr, income, doubles, antara, sales, usa

Oscient's 1st-qtr income doubles on Antara sales

Article | 28 May 2007

The USA's Oscient Pharmaceuticals says that, for the first quarter of 2007, its revenues totaled $23.2 million versus $11.0 million in the like, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antara

Fenofibrate

Factive

Gemifloxacin Mesylate

Fenofibrate 40 mg/ 120 mg

Go to drug listing